| CLASS | PANEL.DRUG/TOX | LP29683-7 |
| COMPONENT | Ravulizumab Monitoring Panel | LP435851-3 |
| PROPERTY | - | LP6769-6 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | - | LP7747-1 |
| parent | Lab terms not yet categorized | LP248770-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Order | |
| PanelType | Panel | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Ravulizumab Monitoring Panel |
| LONG_COMMON_NAME | en-US | Ravulizumab Monitoring Panel |
| SHORTNAME | en-US | Ravulizumab pnl SerPl |
| ConsumerName | en-US | Ravulizumab Monitoring Panel, Blood |
| LONG_COMMON_NAME | fr-FR | Ravulizumab monitoring panel [-] Sérum/Plasma ; - |
| LONG_COMMON_NAME | nl-NL | Monitoring van ravulizumab panel in serum of plasma |
LOINC Version: 2.81
FHIR